Adjustable Continence Therapy - (0573) — MM 0573 | CIGNA Coverage Update

TL;DR: Cigna Healthcare modified MM 0573, its adjustable continence therapy coverage policy, effective September 26, 2025. Both CPT codes tied to this procedure—53451 and 53452—are classified as experimental/investigational/unproven. Here's what billing teams need to do.

If your urology billing team submits claims for the ACT® device (used in women) or the ProACT™ device (used in men), this policy change directly affects your reimbursement outlook with Cigna Healthcare. CPT 53451 and CPT 53452 cover periurethral transperineal adjustable balloon continence device insertion—bilateral and unilateral respectively—and under MM 0573 in the Cigna system, both land squarely in non-covered territory. That's not a gray area. That's a denial waiting to happen if your charge capture hasn't been updated.

Quick-Reference Table

Cigna Adjustable Continence Therapy Coverage Criteria and Medical Necessity Requirements 2025

The Cigna adjustable continence therapy coverage policy under MM 0573 takes a clear position: the ACT® and ProACT™ devices do not meet Cigna's medical necessity standards. Full stop.

That means there are no qualifying criteria that unlock coverage. There's no clinical pathway where a provider documents sufficient conservative treatment failure, sufficient symptom severity, or a sufficient diagnosis that flips 53451 or 53452 into covered territory under this policy. The policy doesn't ask you to prove medical necessity—it rules these procedures out regardless of clinical presentation.

This is the pattern you see when a payer decides the evidence base for a procedure is too thin to support reimbursement. Cigna is saying the data behind adjustable balloon continence devices—whether the ACT® for women or the ProACT™ for men—doesn't clear its bar for proven clinical benefit. Prior authorization won't save you here. Even if a provider calls to verify benefits and gets prior auth approved in error, the underlying policy classification as experimental/investigational/unproven creates real claim denial risk.

If you're billing for urinary incontinence procedures broadly, this coverage policy only addresses the adjustable balloon devices. Other continence interventions may have entirely different coverage status under separate Cigna policies. Don't assume MM 0573 speaks to your entire urology portfolio.

Cigna Adjustable Continence Therapy Exclusions and Non-Covered Indications

This is the core of what MM 0573 says about these procedures: both are experimental, investigational, and unproven.

CPT 53451 (bilateral insertion) and CPT 53452 (unilateral insertion) both fall under the group label "Urology Services Considered Experimental/Investigational/Unproven." That classification isn't a warning or a conditional flag. It's a coverage denial designation.

The practical effect: Cigna will not reimburse claims submitted with CPT 53451 or 53452. It doesn't matter whether you bill bilateral or unilateral. Both routes lead to the same outcome under this policy.

This is worth saying plainly because billing teams sometimes assume unilateral procedures (53452) carry lighter scrutiny than bilateral ones (53451). Under MM 0573, that assumption is wrong. The experimental/investigational classification applies to both codes equally.

For procedures involving the ACT® device in female patients and the ProACT™ device in male patients, Cigna's position as of the effective date of September 26, 2025 is consistent: no coverage, no exceptions documented in this policy. If your practice has been billing these codes to Cigna and receiving payment, pull your remittance history. A policy modification that firms up experimental designation often precedes retroactive audit activity.

Coverage Indications at a Glance

Cigna Adjustable Continence Therapy Billing Guidelines and Action Items 2025

The effective date of September 26, 2025 is your hard line. Here's what to do before and after it.

CPT, HCPCS, and ICD-10 Codes for Adjustable Continence Therapy Under MM 0573

The Cigna adjustable continence therapy billing guidelines under MM 0573 reference two CPT codes. No HCPCS codes and no ICD-10-CM codes appear in the policy data for this coverage policy.

Not Covered / Experimental Codes

Both codes applicable to this procedure carry the experimental/investigational/unproven designation under MM 0573. There are no covered codes associated with this policy.

No ICD-10-CM diagnosis codes are listed in the MM 0573 policy data. If your billing system requires a diagnosis code crosswalk for claim scrubbing purposes, work with your coding team to identify the appropriate urinary incontinence diagnosis codes—but understand that no diagnosis code combination will unlock coverage under this policy.